Monte Rosa Therapeutics Inc (GLUE)

Feb 24, 2025

Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 24, 2025

Feb 24, 2025

Can Monte Rosa's Molecular Glue Technology Transform Drug Development? CEO Presents Latest Advances - StockTitan

Feb 24, 2025

Feb 21, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Short Interest Update - MarketBeat

Feb 21, 2025

Feb 16, 2025

Bullish On Monte Rosa Therapeutics' 'Undruggable' Targets With QuEEN (NASDAQ:GLUE) - Seeking Alpha

Feb 16, 2025

Feb 15, 2025

Janney Montgomery Scott LLC Acquires Shares of 13,315 Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Feb 15, 2025

Feb 12, 2025

SG Americas Securities LLC Has $116,000 Stock Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Feb 12, 2025

Feb 11, 2025

The Potential Rise in the Price of Monte Rosa Therapeutics Inc (GLUE) following insiders activity - Knox Daily

Feb 11, 2025

Feb 05, 2025

BlackRock, Inc. Increases Stake in Monte Rosa Therapeutics Inc - GuruFocus.com

Feb 05, 2025

Feb 05, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Short Interest Up 8.8% in January - MarketBeat

Feb 05, 2025

Feb 03, 2025

JPMorgan Chase & Co. Has $98,000 Stake in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Feb 03, 2025

Jan 31, 2025

Monte Rosa Therapeutics (NASDAQ:GLUE) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Jan 31, 2025

Jan 31, 2025

Vanguard Group Inc. Expands Stake in Monte Rosa Therapeutics Inc. - GuruFocus.com

Jan 31, 2025

Jan 21, 2025

Barclays PLC Acquires 43,499 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jan 21, 2025

Jan 21, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Sees Large Growth in Short Interest - Defense World

Jan 21, 2025

Jan 15, 2025

Jane Street Group LLC Sells 51,005 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jan 15, 2025

Jan 11, 2025

Monte Rosa Therapeutics provide corporate update, key milestones 2025 - Yahoo Finance

Jan 11, 2025

Jan 11, 2025

(GLUE) Technical Data - Stock Traders Daily

Jan 11, 2025

Jan 10, 2025

Monte Rosa outlines 2025 clinical milestones - Investing.com India

Jan 10, 2025

Jan 10, 2025

Monte Rosa outlines 2025 clinical milestones By Investing.com - Investing.com Australia

Jan 10, 2025

Jan 10, 2025

Monte Rosa Therapeutics Outlines 2025 Milestones and Financial Strength - TipRanks

Jan 10, 2025

Jan 10, 2025

Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025 - The Manila Times

Jan 10, 2025

Jan 06, 2025

Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 06, 2025

Jan 06, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Shares Acquired by Barclays PLC - Defense World

Jan 06, 2025

Jan 05, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 05, 2025

Jan 05, 2025

Geode Capital Management LLC Purchases 197,247 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - MarketBeat

Jan 05, 2025

Dec 31, 2024

State Street Corp Raises Stake in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Dec 31, 2024

Dec 23, 2024

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term - Yahoo Finance

Dec 23, 2024

Dec 22, 2024

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 22, 2024

Dec 20, 2024

Wells Fargo Downgrades Monte Rosa Therapeutics (GLUE) - MSN

Dec 20, 2024

Dec 19, 2024

Monte Rosa Therapeutics (NASDAQ:GLUE) Cut to Equal Weight at Wells Fargo & Company - MarketBeat

Dec 19, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Boosts Stock Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Dec 17, 2024

Dec 14, 2024

The Manufacturers Life Insurance Company Buys 15,168 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Dec 14, 2024

Dec 13, 2024

Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors - Marketscreener.com

Dec 13, 2024

Dec 13, 2024

Monte Rosa Therapeutics appoints new board member - Investing.com

Dec 13, 2024

Dec 13, 2024

Monte Rosa Therapeutics appoints new board member By Investing.com - Investing.com UK

Dec 13, 2024

Dec 13, 2024

Monte Rosa Therapeutics Strengthens Board with Teva's R&D Chief, Advancing Molecular Glue Platform - StockTitan

Dec 13, 2024

Dec 12, 2024

Monte Rosa reports promising cancer therapy results By Investing.com - Investing.com Nigeria

Dec 12, 2024

Dec 11, 2024

Monte Rosa reports promising cancer therapy results - Investing.com

Dec 11, 2024

Dec 11, 2024

Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders - The Manila Times

Dec 11, 2024

Dec 11, 2024

Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer - The Manila Times

Dec 11, 2024

Dec 11, 2024

Monte Rosa Therapeutics Announces Closing of Global License - GlobeNewswire

Dec 11, 2024

Dec 11, 2024

Monte Rosa Therapeutics Presents Preclinical Data at the - GlobeNewswire

Dec 11, 2024

Dec 11, 2024

Monte Rosa Secures Landmark $2.1B Novartis Deal for Revolutionary Drug Development Program - StockTitan

Dec 11, 2024

Dec 09, 2024

Intech Investment Management LLC Makes New $77,000 Investment in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Dec 09, 2024

Dec 09, 2024

The 2nd Dimension: VC raises $500M fund for entrepreneurs pioneering life sci, tech - Fierce Biotech

Dec 09, 2024

Dec 07, 2024

Monte Rosa Therapeutics (NASDAQ:GLUE) Shares Up 8.7%Here's What Happened - MarketBeat

Dec 07, 2024